Industry / Spain

Pharmaceutical Growth To Be Hindered By Price Erosion Mechanisms And Patent Cliff

June 2010 | Industry Trend Analysis

Short-Term Outlook: 2010

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

Price Cuts Implemented To Make savings Of US$2.0bn

Industry / Spain With the aim of slashing EUR1.5bn (US$2.0bn) from its annual drugs bill, the Spanish government has implemented a new reference pricing system that includes price cuts of up to 25% on generic medicines....

May 2010

A New Reference Pricing Order Established

Industry / Spain As established under the reforms to Spain's Medicines Law in 2006, reimbursed medicines with the same active ingredient and mode of administration, and which have at least one generic competitor, must...

January 2010

Pharmaceutical Market Growth To Slow

Industry / Spain The Spanish pharmaceuticals market is among the top five in Europe and the top 10 in the world by value. It has grown strongly in recent years, outperforming the majority of others in Western Europe....

December 2009

Faes Farma And Cinfa Partner To Tackle Generic Drugs Market

Industry / Spain Spanish drugmaker Faes Farma has signed an agreement with Laboratorios Cinfa for the joint marketing and distribution of generic drugs in Portugal. BMI commends the focus of the partnership as we forecast...

November 2009

Generic Medicines Industry Association Puts Forward Recommendations To Push Market Sector

Industry / Spain Highlighting Spain as having one of the lowest levels of generic medicines uptake in Europe, the country's generic medicine industry association, AESEG, has put forward key recommendations to stimulate...

October 2009